<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01498601</url>
  </required_header>
  <id_info>
    <org_study_id>FDAAA</org_study_id>
    <nct_id>NCT01498601</nct_id>
  </id_info>
  <brief_title>Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired Adult</brief_title>
  <official_title>Improving Oral Care to Reduce Hospital Acquired Pneumonia (HAP) in the Acute, Non-Intubated, Care Dependent, Neurologically Impaired Adult Patient Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fraser Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fraser Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: The investigators hypothesize that the current oral protocol is sub-optimal and
      an enhanced protocol will decrease the incidence of hospital acquired pneumonia (HAP)in the
      acute, non-intubated, care-dependent, neurologically impaired, adult patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overview Problem: Hospital-acquired pneumonia (HAP) is the second most common nosocomial
      infection and is a significant cause of morbidity and mortality. In the surgical population,
      HAP is associated with a 55% increase in length of stay and increased costs of approximately
      $31,000.00 per case. Neurologically impaired patients (those with brain injury causing
      alterations in mental status, immobility, impaired swallowing and cough, and increased risk
      of aspiration) are particularly vulnerable to HAP. HAP negatively impacts patient comfort and
      satisfaction, increases costs associated with diagnostic tests and treatments, increases risk
      for sepsis, and potential for higher level of care. It is estimated 95% of care-dependent
      patients on the Royal Columbian Hospital (RCH) neuroscience unit acquire HAP during their
      stay.

      Gap: Research studies have shown improving oral hygiene in critical care, neuroscience
      intensive care units and cardiac surgery reduces the incidence of HAP. However, in the
      acutely ill neuroscience population outside critical care areas, this relationship has not
      been determined. Current oral care protocols, products and practitioner practice on
      medical/surgical units such as the RCH neuroscience unit do not consider recent evidence or
      recent increases in patient acuity and complexity.

      Goal: The goal of this study is to test the efficacy of an improved, evidence-based oral care
      protocol in reducing HAP in this population on the medical/surgical neuroscience unit at RCH.

      Research question: Does implementing an enhanced oral care protocol reduce rates of HAP in
      the acute, non-intubated, care-dependent, neurologically impaired, adult patient on a
      neuroscience unit?

      Objective: To measure and compare the incidence of HAP among medical/surgical patients who
      had the current standard of oral care with those receiving an improved, preventative-based,
      oral hygiene protocol including regular teeth brushing, mouth and tongue inspection, swabbing
      and moisturizing, elevation of head of the bed (HOB), changing of suction equipment, and
      universal precautions.

      Relevance: This study may identify the importance of standardizing oral hygiene protocols to
      the evidence, and heighten awareness among care providers in the prevention of HAP. If proven
      successful, the oral care protocol could be considered for implementation on acute units
      outside the RCH neuro unit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital Acquired Pneumonia Occurrences</measure>
    <time_frame>10 months</time_frame>
    <description>Hospital acquired pneumonia is acquired greater than 48 hours after admission and is diagnosed by a positive chest x-ray plus 2 of the following 3 symptoms: presence of fever, elevated serum white blood cells count, and positive sputum specimen.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>Oral care treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects in the prospective intervention group will receive the same enhanced oral care protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrospective study group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>For comparison purposes, a retrospective chart review of matched in-patient population will reveal pneumonia rates in the same population who did not receive the enhanced oral care protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced oral care protocol</intervention_name>
    <description>Changing mouth suction equipment every 24 hours
Mouth assessment every 2-4 hours
Cleansing mouth with toothbrush every 12 hours
Cleansing oral mucosa with oral rinse solution every 2-4 hours
Moisturize mouth/lips with swab and standard mouth moisturizer every 4 hours
Suction mouth and throat as needed
Head of the bed elevated to a minimum of 30Â° during oral care</description>
    <arm_group_label>Oral care treatment group</arm_group_label>
    <other_name>Sage oral care products</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt; 19 years)

          -  Admitted to RCH neuroscience unit

          -  Primary diagnosis is neurological (brain injury/insult)

          -  Non-intubated

          -  Dependent for oral care and unable to direct their own oral care

        Exclusion Criteria:

          -  &lt; 19 years

          -  Off service patients

          -  Intubated, on bilevel positive airway pressure or continuous positive airway pressure
             devices, (respiratory assistive devices)

          -  Palliative

          -  Capable of directing their own oral care

          -  Unable to receive oral care due to: oral tubes, nasal/oral airways, wired jaws, or
             behaviours such as resistiveness, combativeness, non-compliance, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Trudy L. Robertson, MSN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fraser Health Authority</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dulcie J. Carter, MMedSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fraser Health Authority</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Columbian Hospital</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001 Mar 1;344(9):665-71. Review.</citation>
    <PMID>11228282</PMID>
  </reference>
  <reference>
    <citation>Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003 Jul;124(1):328-36. Review.</citation>
    <PMID>12853541</PMID>
  </reference>
  <reference>
    <citation>Munro CL, Grap MJ. Oral health and care in the intensive care unit: state of the science. Am J Crit Care. 2004 Jan;13(1):25-33; discussion 34. Review.</citation>
    <PMID>14735645</PMID>
  </reference>
  <reference>
    <citation>Perry &amp; Potter. Fraser Health Nursing Skills for Mouth Care for the Unconscious or Debilitated Patient. Mosby's Nursing Skills: Clinical Nursing Skills &amp; Techniques (7th Ed.). St. Louis. Retrieved April 14th, 2011 from: http://app44.webinservice.com/NursingSkills/ContentPlayer/SkillContentPlayerIFrame.aspx?KeyId=598&amp;Id=GN_14_3&amp;Section=1&amp;bcp=Index~M~False&amp;IsConnect=False</citation>
  </reference>
  <reference>
    <citation>Shigemitsu H, Afshar K. Aspiration pneumonias: under-diagnosed and under-treated. Curr Opin Pulm Med. 2007 May;13(3):192-8. Review.</citation>
    <PMID>17414126</PMID>
  </reference>
  <reference>
    <citation>Terpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc. 2001 May;49(5):557-63.</citation>
    <PMID>11380747</PMID>
  </reference>
  <results_reference>
    <citation>American Association of Critical Care Nurses. AACN Practice Alert: Oral Care for Patients at Risk for Ventilator-Associated Pneumonia. Retrieved April 10, 2011 from: http://www.aacn.org</citation>
  </results_reference>
  <results_reference>
    <citation>Bopp M, Darby M, Loftin KC, Broscious S. Effects of daily oral care with 0.12% chlorhexidine gluconate and a standard oral care protocol on the development of nosocomial pneumonia in intubated patients: a pilot study. J Dent Hyg. 2006 Summer;80(3):9. Epub 2006 Jul 1.</citation>
    <PMID>16953990</PMID>
  </results_reference>
  <results_reference>
    <citation>Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ. 2007 Apr 28;334(7599):889. Epub 2007 Mar 26. Review.</citation>
    <PMID>17387118</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohn JL, Fulton JS. Nursing staff perspectives on oral care for neuroscience patients. J Neurosci Nurs. 2006 Feb;38(1):22-30.</citation>
    <PMID>16568810</PMID>
  </results_reference>
  <results_reference>
    <citation>DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996 Jun;109(6):1556-61.</citation>
    <PMID>8769511</PMID>
  </results_reference>
  <results_reference>
    <citation>Fields LB. Oral care intervention to reduce incidence of ventilator-associated pneumonia in the neurologic intensive care unit. J Neurosci Nurs. 2008 Oct;40(5):291-8.</citation>
    <PMID>18856250</PMID>
  </results_reference>
  <results_reference>
    <citation>Grap MJ, Munro CL, Ashtiani B, Bryant S. Oral care interventions in critical care: frequency and documentation. Am J Crit Care. 2003 Mar;12(2):113-8; discussion 119.</citation>
    <PMID>12625169</PMID>
  </results_reference>
  <results_reference>
    <citation>Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003 Apr;34(4):975-81. Epub 2003 Mar 13.</citation>
    <PMID>12637700</PMID>
  </results_reference>
  <results_reference>
    <citation>Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002 Nov;11(6):567-70.</citation>
    <PMID>12425407</PMID>
  </results_reference>
  <results_reference>
    <citation>Langmore SE, Terpenning MS, Schork A, Chen Y, Murray JT, Lopatin D, Loesche WJ. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia. 1998 Spring;13(2):69-81.</citation>
    <PMID>9513300</PMID>
  </results_reference>
  <results_reference>
    <citation>Prendergast V, Hallberg IR, Jahnke H, Kleiman C, Hagell P. Oral health, ventilator-associated pneumonia, and intracranial pressure in intubated patients in a neuroscience intensive care unit. Am J Crit Care. 2009 Jul;18(4):368-76. doi: 10.4037/ajcc2009621.</citation>
    <PMID>19556415</PMID>
  </results_reference>
  <results_reference>
    <citation>Reimer-Kent J. From theory to practice: preventing pain after cardiac surgery. Am J Crit Care. 2003 Mar;12(2):136-43.</citation>
    <PMID>12625171</PMID>
  </results_reference>
  <results_reference>
    <citation>Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol. 2008 Jan;19(1):19-53.</citation>
    <PMID>19145262</PMID>
  </results_reference>
  <results_reference>
    <citation>Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005 Jun;50(6):725-39; discussion 739-41. Review.</citation>
    <PMID>15913465</PMID>
  </results_reference>
  <results_reference>
    <citation>Shorr AF, Kollef MH. Ventilator-associated pneumonia: insights from recent clinical trials. Chest. 2005 Nov;128(5 Suppl 2):583S-591S.</citation>
    <PMID>16306057</PMID>
  </results_reference>
  <results_reference>
    <citation>Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg. 2006 Apr;243(4):547-52.</citation>
    <PMID>16552208</PMID>
  </results_reference>
  <results_reference>
    <citation>Yoon, M. &amp; Steele, C. The oral care imperative: The link between oral hygiene and aspiration pneumonia. Topics in Geriatric Rehabilitation. 23(3), 280-288.</citation>
  </results_reference>
  <results_reference>
    <citation>Shi Z, Xie H, Wang P, Zhang Q, Wu Y, Chen E, Ng L, Worthington HV, Needleman I, Furness S. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev. 2013 Aug 13;(8):CD008367. doi: 10.1002/14651858.CD008367.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 25;10 :CD008367.</citation>
    <PMID>23939759</PMID>
  </results_reference>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>December 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2011</study_first_posted>
  <results_first_submitted>March 30, 2015</results_first_submitted>
  <results_first_submitted_qc>August 19, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 22, 2015</results_first_posted>
  <last_update_submitted>August 19, 2015</last_update_submitted>
  <last_update_submitted_qc>August 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral hygiene</keyword>
  <keyword>tracheostomy</keyword>
  <keyword>deglutition disorders</keyword>
  <keyword>enteral nutrition</keyword>
  <keyword>brain injury</keyword>
  <keyword>coma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cytarabine</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Etoposide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The retrospective study group included care-dependent adults with a primary diagnosis of neurological injury/insult (n=51) meeting the inclusion criteria. Enrolled subjects in the prospective study received the experimental protocol (n=32).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Retrospective Study Group</title>
          <description>A retrospective chart review identified matched in-patients meeting the study inclusion criteria.</description>
        </group>
        <group group_id="P2">
          <title>Oral Care Treatment Group</title>
          <description>All subjects in the intervention group received the enhanced oral care protocol:
Changing mouth suction equipment every 24 hours
Mouth assessment every 2-4 hours
Cleansing mouth with toothbrush every 12 hours
Cleansing oral mucosa with oral rinse solution every 2-4 hours
Moisturize mouth/lips with swab and standard mouth moisturizer every 4 hours
Suction mouth and throat as needed
Head of the bed elevated to a minimum of 30Â° during oral care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oral Care Treatment Group</title>
          <description>Subjects were neurologically impaired, dependent adults who met inclusion criteria. Subjects were identified upon admission to the in-patient unit during the study period.</description>
        </group>
        <group group_id="B2">
          <title>Retrospective Study Group</title>
          <description>Subjects were neurologically impaired, dependent adults who met inclusion criteria. Subjects were identified through a retrospective chart review for the same in-patient unit.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="83"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Age &gt;=19</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>The study was conducted on a 31 bed acute neurosurgical unit at a tertiary care trauma hospital in Western Canada. The hospital is one of 12 acute care centers in a large metropolitan health region. The study unit was outside of critical care environments. Unit staff consists of a mix of novice and experienced staff including registered nurses (RNs), licensed practice nurses (LPNs), patient care assistants (PCAs), and a rehabilitation team.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hospital Acquired Pneumonia Occurrences</title>
        <description>Hospital acquired pneumonia is acquired greater than 48 hours after admission and is diagnosed by a positive chest x-ray plus 2 of the following 3 symptoms: presence of fever, elevated serum white blood cells count, and positive sputum specimen.</description>
        <time_frame>10 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Care Treatment Group</title>
            <description>Acute neurologically impaired adults receiving the study protocol</description>
          </group>
          <group group_id="O2">
            <title>Retrospective Study Group</title>
            <description>Acute neurologically impaired adults in the retrospective chart review</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Acquired Pneumonia Occurrences</title>
          <description>Hospital acquired pneumonia is acquired greater than 48 hours after admission and is diagnosed by a positive chest x-ray plus 2 of the following 3 symptoms: presence of fever, elevated serum white blood cells count, and positive sputum specimen.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months.</time_frame>
      <desc>Participants experience included total time receiving treatment up to and not exceeding 6 months.</desc>
      <group_list>
        <group group_id="E1">
          <title>Oral Care Treatment Group</title>
          <description>Subjects meeting the inclusion criteria and identified at the point of admission to the in-patient unit during the study period.</description>
        </group>
        <group group_id="E2">
          <title>Retrospective Study Group</title>
          <description>Subjects were identified through a chart review process for in-patients on the study unit unit during the retrospective study period and met the inclusion criteria .</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>pneumonia</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>pneumonia</sub_title>
                <description>2/32 study subjects acquired pneumonia while on the protocol</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study was supported by the Fraser Health Point of Care Research Challenge.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Trudy Robertson RN, MSN, CNN(c)</name_or_title>
      <organization>Fraser Health</organization>
      <phone>604-520-4715</phone>
      <email>Trudy.Robertson@fraserhealth.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

